We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMT
1201
DELISTED
Chemtura Corporation
CHMT
| $375K | 0.01% |
+13,753
| New | +$409K |
|
|
DNKN
1202
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $374K | 0.01% |
8,792
+1,632
| +23% | +$68.5K |
|
|
AET
1203
DELISTED
Aetna Inc
AET
| $374K | 0.01% |
3,461
-27,325
| -89% | -$2.95M |
|
1204
Old National Bancorp
ONB
$10.3B
| $373K | 0.01% |
27,530
+11,343
| +70% | +$160K |
|
1205
Jabil
JBL
$30.5B
| $372K | 0.01% |
15,955
-19,792
| -55% | -$471K |
|
1206
Omnicell
OMCL
$2.01B
| $371K | 0.01% |
+11,934
| New | +$352K |
|
1207
Dorman Products
DORM
$4.31B
| $370K | 0.01% |
+7,784
| New | +$380K |
|
|
FOLD
1208
DELISTED
Amicus Therapeutics
FOLD
| $370K | 0.01% |
+38,096
| New | +$343K |
|
1209
Graphic Packaging
GPK
$3.32B
| $368K | 0.01% |
28,630
-6,648
| -19% | -$89.3K |
|
1210
International Flavors & Fragrances
IFF
$20.3B
| $368K | 0.01% |
+3,076
| New | +$356K |
|
|
TUP
1211
DELISTED
Tupperware Brands Corporation
TUP
| $367K | 0.01% |
+6,597
| New | +$371K |
|
1212
Baidu
BIDU
$36.4B
| $365K | 0.01% |
1,933
-4,290
| -69% | -$791K |
|
1213
Invesco Mortgage Capital
IVR
$764M
| $365K | 0.01% |
2,949
+1,436
| +95% | +$183K |
|
|
DISCK
1214
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $365K | 0.01% |
+14,467
| New | +$395K |
|
|
SALE
1215
DELISTED
RetailMeNot, Inc. Series 1
SALE
| $363K | 0.01% |
+36,600
| New | +$353K |
|
1216
Crane NXT
CXT
$3.01B
| $362K | 0.01% |
21,806
-10,732
| -33% | -$186K |
|
|
RPAI
1217
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $361K | 0.01% |
24,430
+13,474
| +123% | +$199K |
|
1218
CALL
Chevron
CVX
$382B
| $360K | 0.01% |
4,000
-44,000
| -92% | -$3.97M |
|
|
1219
PUT
Chevron
CVX
$382B
| $360K | 0.01% |
4,000
-8,000
| -67% | -$721K |
|
1220
CALL
Weyerhaeuser
WY
$17.6B
| $360K | 0.01% |
12,000
-20,000
| -63% | -$603K |
|
|
1221
PUT
Weyerhaeuser
WY
$17.6B
| $360K | 0.01% |
12,000
-20,000
| -63% | -$603K |
|
|
SAFE
1222
Safehold
SAFE
$1.19B
| $358K | 0.01% |
+6,263
| New | +$383K |
|
1223
iShares MSCI EAFE ETF
EFA
$77.3B
| $356K | 0.01% |
+6,049
| New | +$364K |
|
1224
Hilltop Holdings
HTH
$2.27B
| $356K | 0.01% |
+18,502
| New | +$386K |
|
1225
Urban Outfitters
URBN
$6.5B
| $356K | 0.01% |
+15,640
| New | +$404K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.